TY - STD TI - Lutz J, Menke J, Sollinger D, Schinzel H, Thürmel K. Haemostasis in chronic kidney disease. Nephrol Dial Transplant. 2014. doi:10.1093/ndt/gft209. ID - ref1 ER - TY - STD TI - Danaei G, Lu Y, Singh GM, Carnahan E, Stevens GA, Cowan MJ, et al. Global burden of metabolic risk factors for chronic diseases collaboration: cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diab Endocrinol. 2014. doi:10.1016/S2213-8587(14)70102-0. ID - ref2 ER - TY - STD TI - Lekawanvijit S, Krum H. Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J Physiol. 2014. doi:10.1113/jphysiol.2014.273078. ID - ref3 ER - TY - STD TI - Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008. doi:10.1016/j.pop.2008.01.008. ID - ref4 ER - TY - STD TI - Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014. doi:10.4103/0019-5049.144643. ID - ref5 ER - TY - STD TI - Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011. doi:10.1152/physrev.00047.2009. ID - ref6 ER - TY - STD TI - Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev. 2012. doi:10.1007/s10741-011-9261-3. ID - ref7 ER - TY - STD TI - Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012. doi:10.4103/2230-8210.93737. ID - ref8 ER - TY - STD TI - Mutsaers HA, Engelke UF, Wilmer MJ, Wetzels JF, Wevers RA, van den Heuvel LP, et al. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3–4 chronic kidney disease patients. PLoS One. 2013. doi:10.1371/journal.pone.0071199. ID - ref9 ER - TY - JOUR AU - Niwa, T. PY - 2010 DA - 2010// TI - Uremic toxicity of indoxyl sulfate JO - Nagoya J Med Sci VL - 72 ID - Niwa2010 ER - TY - JOUR AU - Barisione, C. AU - Ghigliotti, G. AU - Canepa, M. AU - Balbi, M. AU - Brunelli, C. AU - Ameri, P. PY - 2015 DA - 2015// TI - Indoxyl sulfate: a candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease JO - Curr Drug Targets VL - 16 UR - https://doi.org/10.2174/1389450116666141230114500 DO - 10.2174/1389450116666141230114500 ID - Barisione2015 ER - TY - STD TI - Ng HY, Yisireyili M, Saito S, Lee CT, Adelibieke Y, Nishijima F, et al. Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells. PLoS One. 2014. doi:10.1371/journal.pone.0091517. ID - ref12 ER - TY - STD TI - Barisione C, Garibaldi S, Furfaro AL, Nitti M, Palmieri D, Passalacqua M, et al. Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages. PLoS One. 2016. doi:10.1371/journal.pone.0149276. ID - ref13 ER - TY - STD TI - Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, et al. The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. J Am Soc Nephrol. 2016. doi:10.1681/ASN.2014121241. ID - ref14 ER - TY - STD TI - Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER, et al. Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation. 2013. doi:10.1161/CIRCULATIONAHA.112.118174. ID - ref15 ER - TY - STD TI - Tang WH, Wang CP, Chung FM, Huang LL, Yu TH, Hung WC, et al. Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS One. 2015. doi:10.1371/journal.pone.0119545. ID - ref16 ER - TY - STD TI - Wang Q, Liu D, Song P, Zou MH. Deregulated tryptophan-kynurenine pathway is linked to inflammation, oxidative stress, and immune activation pathway in cardiovascular diseases. Front Biosci. (Landmark Ed.). 2015;20:1116–43. ID - ref17 ER - TY - STD TI - Al Za'abi M, Ali B, Al Toubi M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. J Chromatogr Sci. 2013. doi:10.1093/chromsci/bms103. ID - ref18 ER - TY - JOUR AU - Liu, M. AU - Li, X. C. AU - Lu, L. AU - Cao, Y. AU - Sun, R. R. AU - Chen, S. PY - 2014 DA - 2014// TI - Cardiovascular disease and its relationship with chronic kidney disease JO - Eur Rev Med Pharmacol Sci VL - 18 ID - Liu2014 ER - TY - STD TI - Zahran M, Nasr FM, Metwaly AA, El-Sheikh N, Khalil NS, Harba T. The role of hemostatic factors in atherosclerosis in patients with chronic renal disease. Electron Physician. 2015. doi:10.14661/1270. ID - ref20 ER - TY - STD TI - Christiansen CF, Schmidt M, Lamberg AL, Horváth-Puhó E, Baron JA, Jespersen B, et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case–control study. J Thromb Haemost. 2014. doi:10.1111/jth.12652. ID - ref21 ER - TY - STD TI - Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res. 2012. doi:10.1161/CIRCRESAHA.112.278457. ID - ref22 ER - TY - STD TI - Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. European Uremic Toxin Work Group (EUTox).: Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009. doi:10.2215/CJN.03980609. ID - ref23 ER - TY - STD TI - Pawlak K, Pawlak D, Mysliwiec M. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem. 2005. doi:10.1016/j.clinbiochem.2005.02.009. ID - ref24 ER - TY - STD TI - Huber C, JR Batchelor, Fuchs D. Immune response associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984. doi:10.1084/jem.160.1.310 ID - ref25 ER - TY - STD TI - Maciel RA, Rempel LC, Bosquetti B, Finco AB, Pecoits-Filho R, Souza WM, et al. p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-κB p65 in human vascular smooth muscle cells. J Bras Nefrol. 2016. doi:10.5935/0101-2800.20160024. ID - ref26 ER - TY - STD TI - Masai N, Tatebe J, Yoshino G, Morita T. Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway. Circ J. 2010. doi:10.1253/circj.CJ-10-0117. ID - ref27 ER - TY - STD TI - Ito S, Higuchi Y, Yagi Y, Nishijima F, Yamato H, Ishii H. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J Leukoc Biol. 2013. doi:10.1189/jlb.0112023. ID - ref28 ER - TY - STD TI - Pawlak K, Pawlak D, Mysliwiec M. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients. Thromb Res. 2007. doi:10.1016/j.thromres.2007.01.011. ID - ref29 ER - TY - STD TI - Pawlak K, Buraczewska-Buczko A, Mysliwiec M, Pawlak D. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment. Am J Med Sci. 2010. doi:10.1097/MAJ.0b013e3181b922a4. ID - ref30 ER - TY - STD TI - Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B, et al. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney Int. 2015. doi:10.1038/ki.2014.197. ID - ref31 ER - TY - JOUR AU - Hadi, H. A. AU - Carr, C. S. AU - Al, S. J. PY - 2005 DA - 2005// TI - Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome JO - Vasc Health Risk Manag VL - 1 ID - Hadi2005 ER - TY - JOUR AU - Rosenberg, R. D. AU - Bauer, K. A. PY - 1993 DA - 1993// TI - Prothrombin activation fragment assay JO - Clin Chem VL - 39 ID - Rosenberg1993 ER - TY - JOUR AU - Chavakis, T. AU - Willuweit, A. K. AU - Lupu, F. AU - Preissner, K. T. AU - Kanse, S. M. PY - 2001 DA - 2001// TI - Release of soluble urokinase receptor from vascular cells JO - Thromb Haemost VL - 86 ID - Chavakis2001 ER - TY - STD TI - Lindmark T, Chen S. IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. Brit. J Haematol. 1998. doi:10.1046/j.1365-2141.1998.00808.x. ID - ref35 ER - TY - STD TI - Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, et al. Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. Clin Immunol. 2009. doi:10.1016/j.clim.2009.01.007. ID - ref36 ER - TY - STD TI - Gondouin B, Cerini C, Dou L, Sallée M, Duval-Sabatier A, Pletinck A, et al. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int. 2013. doi:10.1038/ki.2013.133. ID - ref37 ER - TY - JOUR AU - Lijnen, H. R. AU - Collen, D. PY - 1995 DA - 1995// TI - Mechanisms of physiological fibrinolysis JO - Baillieres Clin Haematol (Bailliera Tindall, London, UK) VL - 8 UR - https://doi.org/10.1016/S0950-3536(05)80268-9 DO - 10.1016/S0950-3536(05)80268-9 ID - Lijnen1995 ER - TY - STD TI - Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000. doi:10.1161/01.ATV.20.10.2175. ID - ref39 ER - TY - STD TI - Chen JW, Lin FY, Chen YH, Wu TC, Chen YL, Lin SJ. Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc. 2014. doi:10.1161/01.ATV.0000145016.69181.fa. ID - ref40 ER - TY - STD TI - Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta. 2008. doi:10.1016/j.bbamcr.2008.01.004. ID - ref41 ER - TY - STD TI - Stinghen AE, Gonçalves SM, Martines EG, Nakao LS, Riella MC, Aita CA, et al. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract. 2009. doi:10.1159/000191205. ID - ref42 ER - TY - STD TI - Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T. Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol. 2010. doi:10.1159/000299798. ID - ref43 ER - TY - STD TI - Lin CJ, Pan CF, Liu HL, Chuang CK, Jayakumar T, Wang CJ, et al. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis. Atherosclerosis. 2012. doi:10.1016/j.atherosclerosis.2012.07.012. ID - ref44 ER - TY - STD TI - Lin CJ, Wu V, Wu PC, Wu CJ. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. PLoS One. 2015. doi:10.1371/journal.pone.0132589. ID - ref45 ER - TY - STD TI - Chen J, Hamm LL, Mohler ER, Hudaihed A, Arora R, Chen CS, et al. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease PLoS One. 2015. doi:10.1371/journal.pone.0132047. ID - ref46 ER - TY - JOUR AU - Cines, D. B. AU - Pollak, E. S. AU - Buck, C. A. AU - Loscalzo, J. AU - Zimmerman, G. A. AU - McEver, R. P. PY - 1998 DA - 1998// TI - Endothelial cells in physiology and in the pathology of vascular disorders JO - Blood VL - 91 ID - Cines1998 ER - TY - STD TI - Dong J, Li YJ, Yang ZK, Xu R. Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients. Perit Dial Int. 2014. doi:10.3747/pdi.2012.00004. ID - ref48 ER - TY - STD TI - Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010. doi:10.1111/j.1365-2796.2010.02252.x. ID - ref49 ER - TY - STD TI - Pawlak K, Myśliwiec M, Pawlak D. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients. Adv Med Sci. 2010. doi:10.2478/v10039-010-0015-6. ID - ref50 ER - TY - STD TI - Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant. 2010. doi:10.1093/ndt/15.10.1624. ID - ref51 ER - TY - STD TI - Avci E, Coskun S, Cakir E, Kurt Y, Ozgur Akgul E, Bilgi C. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Ren Fail. 2008. doi:10.1080/08860220802249009. ID - ref52 ER -